| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 10/07/1999 | CA2324864A1 Immune response modulator alpha-2 macroglobulin complex |
| 10/07/1999 | CA2324652A1 Nek1-related protein kinase |
| 10/07/1999 | CA2324511A1 Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 10/07/1999 | CA2324477A1 Use of active p40 conjugates for nasal delivery |
| 10/07/1999 | CA2324441A1 Materials and methods relating to a novel retrovirus |
| 10/07/1999 | CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof |
| 10/07/1999 | CA2322203A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 10/07/1999 | CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils |
| 10/06/1999 | EP0947524A1 Novel peptides for the treatment of autoimmune diseases |
| 10/06/1999 | EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors |
| 10/06/1999 | EP0946730A2 Mutants of streptococcal toxin c and methods of use |
| 10/06/1999 | EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 10/06/1999 | EP0946722A1 Human apoptosis-related calcium-binding protein |
| 10/06/1999 | EP0946714A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
| 10/06/1999 | EP0946596A1 Peptide derivatives |
| 10/06/1999 | EP0946592A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 10/06/1999 | EP0946589A1 Inhibitors of peptide binding to mhc class ii proteins |
| 10/06/1999 | EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS |
| 10/06/1999 | EP0946557A1 A-1-adenosine receptor antagonists |
| 10/06/1999 | EP0946541A1 Quinolines and their therapeutic use |
| 10/06/1999 | EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| 10/06/1999 | EP0946200A1 Immunization of infants |
| 10/06/1999 | EP0832900A4 Peptide and method of obtaining it |
| 10/06/1999 | CN1230892A Use of proteins as agents against autoimmune diseases |
| 10/06/1999 | CN1230549A Escape mutant of surface antigen of hepatitis B virus |
| 10/06/1999 | CN1045431C 15-deoxyspergualin analogs, their preparation method, compositions, intermediate and use in preparation of medicine thereof |
| 10/05/1999 | US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize |
| 10/05/1999 | US5962635 Therapeutic compounds |
| 10/05/1999 | US5962531 5-aroylnaphthalene derivatives as anti-inflammatory agents |
| 10/05/1999 | US5962525 6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same |
| 10/05/1999 | US5962492 Antiasthma agents; antiinflammatory agents |
| 10/05/1999 | US5962479 Psychological and nervous sytem disorders |
| 10/05/1999 | US5962473 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
| 10/05/1999 | US5962471 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids |
| 10/05/1999 | US5962464 Side effect reduction |
| 10/05/1999 | US5962415 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof |
| 10/05/1999 | US5962331 Cell growth regulator |
| 10/05/1999 | US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.? |
| 10/05/1999 | US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses. |
| 10/05/1999 | US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system. |
| 10/05/1999 | US5962216 Tumor-activated prodrug compounds and treatment |
| 10/05/1999 | US5962019 Alkanol solvent of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant. |
| 10/05/1999 | US5961979 Complex of a mammalian stress protein noncovalently associated with a peptide that is present in a eukaryotic cell infected with said pathogen but not present in said cell when said cell is not infected with said pathogen |
| 10/05/1999 | US5961978 Therapeutically useful peptides and peptide fragments |
| 10/05/1999 | US5961977 Orally administering an autoantigen |
| 10/05/1999 | US5961976 Monoclonal antibodies characterized by their ability to neutralize in vitro and in vivo primary isolates of human immunodeficiency virus (hiv) and related immunodeficiency viruses. |
| 10/05/1999 | US5961975 Type I surface antigen associated with staphylococcus epidermidis |
| 10/05/1999 | US5961970 Submicron emulsions as vaccine adjuvants |
| 10/05/1999 | US5961955 Radioprotectant for peptides labeled with radioisotope |
| 10/05/1999 | CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists |
| 10/05/1999 | CA1340776C Multispecific antigenic proteins |
| 09/30/1999 | WO1999049067A1 Nucleic acid transfer vectors, compositions containing same and uses |
| 09/30/1999 | WO1999049055A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | WO1999049038A2 Human calcium-binding proteins |
| 09/30/1999 | WO1999049037A2 Protein phosphatase-related molecules |
| 09/30/1999 | WO1999049033A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | WO1999049018A1 Glycosyl sulfotransferase-3 |
| 09/30/1999 | WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | WO1999048910A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 09/30/1999 | WO1999048879A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins |
| 09/30/1999 | WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 09/30/1999 | WO1999048524A1 Use of cytokines and mitogens to inhibit graft versus host disease |
| 09/30/1999 | WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 09/30/1999 | WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis |
| 09/30/1999 | WO1999036562A9 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 09/30/1999 | WO1999035277A3 Recombinant, active caspases and uses thereof |
| 09/30/1999 | WO1999035266A3 Human urotensin ii |
| 09/30/1999 | WO1999032449A3 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
| 09/30/1999 | CA2325585A1 Inflammatory mediator antagonists |
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | CA2323831A1 Nucleic acid transfer vectors, compositions containing same and uses |
| 09/30/1999 | CA2323760A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | CA2323640A1 Human calcium-binding proteins |
| 09/30/1999 | CA2323605A1 Protein phosphatase-related molecules |
| 09/30/1999 | CA2323601A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | CA2323063A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 09/30/1999 | CA2322779A1 Glycosyl sulfotransferase-3 |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945461A1 Lipopeptides inducing T-cyxtotoxic lymphocytes and their use as vaccines |
| 09/29/1999 | EP0945443A1 HIV inhibiting pyrimidine derivatives |
| 09/29/1999 | EP0945135A2 Treatment of alzheimer's disease and modulation of immune system with Delta5-Androstenes |
| 09/29/1999 | EP0944720A1 Adaptor protein frs2 and related products and methods |
| 09/29/1999 | EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944636A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944614A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/29/1999 | EP0944599A1 Triarylethanes useful as pde iv inhibitors |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944397A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 09/29/1999 | EP0944395A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye |
| 09/29/1999 | EP0833842B1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 09/29/1999 | EP0591281B1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 09/29/1999 | CN1230223A High-affinity interleukin-4 muteins |
| 09/29/1999 | CN1230222A PTX-sensitive G proteins, prodn. and use thereof |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230195A Treatment of immune disorders |